Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats

Gastroenterology

Volumn 130, Issue 3, 2006, Pages 838-854

  Hennenberg, Martin ^a,c   Biecker, Erwin ^a   Trebicka, Jonel ^a   Jochem, Kerstin ^a   Zhou, Qi ^a   Schmidt, Martina ^b   Jakobs, Karl H ^b   Sauerbruch, Tilman ^a   Heller, Jörg ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; METHOXAMINE; MOESIN; RHO KINASE; RHO KINASE INHIBITOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY CIRRHOSIS; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; DRUG MECHANISM; GENE TRANSLOCATION; HEART MUSCLE CONTRACTILITY; HEMODYNAMICS; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC VASCULAR RESISTANCE; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; VASODILATATION; WESTERN BLOTTING;

EID: 33644870801     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.11.029     Document Type: Article

References (61)

1. J.F. Murray, A.M. Dawson, S. Sherlock Circulatory changes in chronic liver disease Am J Med 24 1958 358 367
2. R.J. Groszmann Hyperdynamic circulation of liver disease 40 years later pathophysiology and clinical consequences Hepatology 20 1994 1359 1363
3. J. Vorobioff, J. Bredfeldt, R. Groszmann Hyperdynamic circulation in portal hypertensive rat model a primary factor for maintenance of chronic portal hypertension Am J Physiol 244 1983 G52 G57
4. F.Y. Lee, A. Albillos, L.A. Colombato, R.J. Groszmann The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats Hepatology 16 1992 1043 1048
5. G-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats Hepatology 17 1993 84 90
6. C.C. Sieber, R.J. Groszmann In vitro hyporeactivity to methoxamine in portal hypertensive rats reversal by nitric oxide blockade Am J Physiol Gastrointest Liver Physiol 262 1992 G996 G1001
7. C.C. Sieber, R.J. Groszmann Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats Gastroenterology 103 1992 235 239
8. C.C. Sieber, J.C. Lopez-Talavera, R.J. Groszmann Role of nitric oxide in the in vitro splanchnic hyporeactivity in ascitic cirrhotic rats Gastroenterology 104 1993 1750 1754
9. J. Heller, M. Schepke, N. Gehnen, G. Molderings, A. Müller, J. Erhard Altered adrenergic responsiveness of endothelium denuded hepatic arteries and portal veins in patients with cirrhosis Gastroenterology 116 1999 387 393
10. M. Schepke, J. Heller, S. Paschke, J. Thomas, M. Wolff, M. Neef Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis evidence for a receptor-specific mechanism Hepatology 34 2001 884 888
11. P.P. Michielsen, G.E. Boeckxstaens, S.U. Sys, A.G. Herman, P.A. Pelckmans The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats J Hepatol 23 1995 341 347
12. Y. Iwakiri, G. Cadelina, W.C. Sessa, R.J. Groszmann Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension Am J Physiol Gastrointest Liver Physiol 283 2002 G1074 G1081
13. A.P. Somlyo, X. Wu, L.A. Walker, A.V. Somlyo Pharmacomechanical coupling the role of calcium, G-proteins, kinases and phosphatases Rev Physiol Biochem Pharmacol 134 1999 201 234
14. A.P. Somlyo, A.V. Somlyo Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II J Physiol 522 2000 177 185
15. A.L. Bishop, A. Hall Rho GTPases and their effector proteins Biochem J 348 2000 241 255
16. M. Uehata, T. Ishizaki, H. Satoh, T. Ono, T. Kawahara T Morishita Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension Nature 389 1997 990 994
17. 2+ sensitivity of smooth muscle and nonmuscle myosin II modulated by G proteins, kinases, and myosin phosphatase Physiol Rev 83 2003 1325 1358
18. S. Sakurada, H. Okamoto, N. Takuwa, N. Sugimoto, Y. Takuwa Rho activation in agonist-stimulated vascular smooth muscle Am J Physiol Cell Physiol 281 2001 C571 C578
19. K. Riento, A.J. Ridley Rocks multifunctional kinases in cell behaviour Nature Rev Mol Cell Biol 4 2003 446 456
20. S. Etienne-Manneville, A. Hall Rho GTPases in cell biology Nature 420 2002 629 635
21. J. Heller, T. Shiozawa, J. Trebicka, M. Hennenberg, M. Schepke, M. Neef Acute hemodynamic effects of losartan in anaesthetized cirrhotic rats Eur J Clin Invest 33 2003 1006 1012
22. M. Neef, E. Biecker, J. Heller, M. Schepke, H.D. Nischalke, M. Wolff Portal hypertension is associated with increased mRNA levels of vasopressor G-protein-coupled receptors in human hepatic arteries Eur J Clin Invest 33 2003 249 255
23. X.D. Ren, M.A. Schwartz Determination of GTP loading on Rho Methods Enzymol 325 2000 264 272
24. Y. Fukuta, N. Oshiro, K. Kaibuchi Activation of moesin and adducin by Rho-kinase downstream of Rho Biophys Chem 82 1999 139 147
25. N. Oshiro, Y. Fukata, K. Kaibuchi Phosphorylation of moesin by rho-associated kinase (Rho-kinase) plays a crucial role in the formation of microvilli-like structures J Biol Chem 273 1998 34663 34666
26. Y. Fukuta, K. Kimura, N. Oshiro, H. Saya, Y. Matsuura, K. Kaibuchi Association of the myosin-binding subunit of myosin phosphatase and moesin dual regulation of moesin phosphorylation by Rho-associated kinase and myosin phosphatases J Cell Biol 141 1998 409 418
27. M. Retzer, M. Essler Lysophosphatidic acid-induced platelet shape change proceeds via Rho/Rho kinase-mediated myosin light-chain and moesin phosphorylation Cell Signal 12 2000 645 648
28. R.J. Shaw, M. Henry, F. Solomon, T. Jacks RhoA-dependent phosphorylation and relocalization of ERM proteins into apical membrane/actin protrusions in fibroblasts Mol Biol Cell 9 1998 403 419
29. T. Matsui, M. Maeda, Y. Doi, S. Yonemura, M. Amano, K. Kaibuchi, S. Tsukita, S. Tsukita Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association J Cell Biol 140 1998 647 657
30. W.C. Seyde, D.E. Longnecker Anesthetic influence on regional hemodynamics in normal and hemorrhaged rats Anesthesiology 61 1984 686 698
31. M. Van de Casteele, H. Sägesser, H. Zimmermann, J. Reichen Characterization of portal hypertension models by microspheres in anaesthetised rats a comparison of liver flow Pharmacol Ther 90 2001 35 43
32. H. Kojima, J. Yamao, T. Tsujimoto, M. Uemura, A. Takaya, H. Fukui Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance J Hepatol 32 2000 43 50
33. J.P. Hakkinen, M.W. Miller, A.H. Smith, D.R. Knight Measurement of organ blood flow with coloured microspheres in the rat Cardiovasc Res 29 1995 74 79
34. D. Pateron, F. Oberti, P. Lefilliatre, N. Veal, K.A. Tazi, P. Sogni Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis Clin Sci 97 1999 313 318
35. A. Castro, W. Jimenez, J. Claria, J. Ros, J. Martinez, M. Bosch Impaired responsiveness to angiotensin II in experimental cirrhosis role of nitric oxide Hepatology 18 1993 367 372
36. J. Polio, C.C. Sieber, E. Lerner, R.J. Groszmann Cardiovascular hyporesponsiveness to norepinephrine, propranolol, and nitroglycerin in portal-hypertensive and aged rats Hepatology 18 1993 128 136
37. A. Bomzon, L.M. Blendis Vascular reactivity in experimental portal hypertension Am J Physiol 257 1987 G158 G162
38. P. Sogni, S. Sabry, R. Moreau, A. Gadano, D. Lebrec, A.T. Dinh-Xuan Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats J Hepatol 25 1996 487 490
39. Y.T. Huang, G.F. Wang, M.C.M. Yang, S.P. Chang, H.C. Lin, C.Y. Hong Vascular hyporesponsiveness in aorta from portal hypertensive rats possible sites of involvement J Pharmacol Exp Ther 278 1996 535 541
40. 1-adrenoceptors of portal hypertensive rats Br J Pharmacol 111 1994 439 444
41. M. Islam, B. Williams, K. Madhavan, P. Hayes, P. Hadoke Selective alteration of agonist-mediated contraction in hepatic arteries isolated from patients with cirrhosis Gastroenterology 118 2000 765 771
42. P.W.F. Hadoke, P.C. Hayes In vitro evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis Pharmacol Ther 75 1997 51 68
43. R. Wiest, R.J. Groszmann The paradox of nitric oxide in cirrhosis and portal hypertension too much, not enough Hepatology 35 2002 478 491
44. S. Moncada, D.D. Rees, R. Schulz, R.M. Palmer Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo Proc Natl Acad Sci U S A 88 1991 2166 2170
45. S. Topouzis, C. Schott, J.C. Stoclet Participation of endothelium-derived relaxing factor and role of cyclic GMP in inhibitory effects of endothelium on contractile responses elicited by α-adrenoceptor agonists in rat aorta J Cardiovasc Pharmacol 18 1991 670 678
46. M.E. Gold, K.S. Wood, R.E. Byrns, J. Fukuto, L.J. Ignarro NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein Proc Natl Acad Sci U S A 87 1990 4430 4434
47. J.D. Frew, K. Paisley, W. Martin Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L- arginine Br J Pharmacol 110 1993 1003 1008
48. N. Wettschureck, S. Offermanns Rho/Rho-kinase mediated signaling in physiology and pathophysiology J Mol Med 80 2002 629 638
49. G. Pawlak, D.M. Helfman Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts Mol Biol Cell 13 2002 336 347
50. R.M. Touyz, E.L. Schiffrin Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells Pharmacol Rev 52 2000 639 672
51. S. Eguchi, T. Inagami Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase Regul Pept 91 2000 13 20
52. W.E. Miller, R.J. Lefkowitz Expanding roles for β-arrestins as scaffolds and adapters in GPCR signaling and trafficking Curr Opin Cell Biol 13 2001 139 145
53. C. Gaudin, J.M. Launay, R. Moreau, S. Cailmail, D. Lebrec Discrepant regulation among α and β adrenoceptors in vascular walls of cirrhotic rats (abstr) J Hepatol 21 1994 S43
54. 2+ sensitization of contraction in vascular smooth muscle J Biol Chem 275 2000 21722 21729
55. A.J. Morris, C.C. Malbon Physiologic regulation of G protein-linked signaling Physiol Rev 79 1999 1373 1430
56. S. Ayman, P. Wallace, C.P. Wayman, A. Gibson, I. McFadzean Receptor-independent activation of Rho-kinase-mediated calcium sensitisation in smooth muscle Br J Pharmacol 139 2003 1532 1538
57. 2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction Circ Res 93 2003 548 556
58. M. Mita, H. Yanagihara, S. Hishinuma, M. Saito, M.P. Walsh Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase Biochem J 364 2002 431 440
59. 2+ sensitization of arterial muscle Am J Physiol Cell Physiol 285 2003 C1377 C1385
60. +-induced contraction by the ROCKs inhibitor Y-27632 in vascular smooth muscle possible involvement of ROCKs in a signal transduction pathway J Pharmacol Sci 92 2003 56 69
61. P.H. Ratz, K.M. Berg, N.H. Urban, A.S. Miner Regulation of smooth muscle calcium sensitivity KCl as a calcium-sensitizing stimulus Am J Physiol Cell Physiol 288 2005 C769 C783